Table 2 Incidence among histologic subtypes
Author | Histologic subtypes | % (N) |
|---|---|---|
Carpenter S.G. et al. [11] | LGMN | 0% |
Mucinous AdenoCa | 20% (1) | |
In situ AdenoCa | 20%(1) | |
Adenocarcinoma | 40%(2) | |
Carcinoid | 20%(1) | |
Lee W.S. et al. [12] | LGMN | 50%(14) |
Mucinous AdenoCa | 11%(3) | |
In situ AdenoCa | 0% | |
Adenocarcinoma | 7%(2) | |
Carcinoid | 32%(9) | |
Wright G.P. et al. [8] | LGMN | |
Mucinous AdenoCa | 55%(6) | |
In situ AdenoCa | 0% | |
Adenocarcinoma | 9%(1) | |
Carcinoid | 36%(4) | |
Lai H.W. et al. [13] | LGMN | 80%(5) |
Mucinous AdenoCa | 0% | |
In situ AdenoCa | 0% | |
Adenocarcinoma | 20%(2) | |
Carcinoid | ||
Furman M.J. et al. [14] | LGMN | 100%(5) |
Mucinous AdenoCa | ||
In situ AdenoCa | ||
Adenocarcinoma | ||
Carcinoid | ||
Cerame M.A. et al. [15] | LGMN | 0% |
Mucinous AdenoCa | 40%(79) | |
In situ AdenoCa | 1%(2) | |
Adenocarcinoma | 59%(117) | |
Carcinoid | ||
Tingstedt B. et al. [16] | LGMN | 33%(1) |
Mucinous AdenoCa | 0% | |
In situ AdenoCa | 0% | |
Adenocarcinoma | 66%(2) | |
Carcinoid | 0% |